仙琚製藥(002332.SZ):甲潑尼龍片4mg被批准註冊
格隆匯8月21日丨仙琚製藥(002332.SZ)公佈,公司於近日收到國家藥品監督管理局核准簽發的關於甲潑尼龍片的《藥品補充申請批准通知書》(證書編號:2024B03743),公司甲潑尼龍片4mg被批准註冊。
甲潑尼龍是一種人工合成的不含鹵素的糖皮質激素藥物,具有強大的抗炎、免疫抑制、抗過敏、抗休克等藥理作用。甲潑尼龍片臨牀應用廣泛,主要用於治療風濕性疾病、膠原疾病、皮膚疾病、過敏狀態、眼部疾病、呼吸道疾病等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.